These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 25494843)

  • 1. Specific antidotes in development for reversal of novel anticoagulants: a review.
    Gomez-Outes A; Suarez-Gea ML; Lecumberri R; Terleira-Fernandez AI; Vargas-Castrillon E
    Recent Pat Cardiovasc Drug Discov; 2014; 9(1):2-10. PubMed ID: 25494843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
    Tummala R; Kavtaradze A; Gupta A; Ghosh RK
    Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of direct oral anticoagulants: a practical approach.
    Shih AW; Crowther MA
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):612-619. PubMed ID: 27913536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Direct oral anticoagulant associated bleeding].
    Godier A; Martin AC; Rosencher N; Susen S
    J Mal Vasc; 2016 Jul; 41(4):272-8. PubMed ID: 27297642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal strategies in patients treated with direct oral anticoagulants.
    Gressenberger P
    Vasa; 2019 Aug; 48(5):389-392. PubMed ID: 30719950
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants.
    Enriquez A; Lip GY; Baranchuk A
    Europace; 2016 Jul; 18(7):955-64. PubMed ID: 25816811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of Anticoagulation and Management of Bleeding in Patients on Anticoagulants.
    Dhakal P; Rayamajhi S; Verma V; Gundabolu K; Bhatt VR
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):410-415. PubMed ID: 27789605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present Knowledge on Direct Oral Anticoagulant and Novel Oral Anti Coagulants and Their Specific Antidotes: A Comprehensive Review Article.
    Biswas S; Bahar Y; Bahar AR; Safiriyu I; Mathai SV; Hajra A; Gupta R; Aronow WS
    Curr Probl Cardiol; 2023 Feb; 48(2):101483. PubMed ID: 36336118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal bleeding in patients receiving oral anticoagulation: Current treatment and pharmacological perspectives.
    Di Minno A; Spadarella G; Spadarella E; Tremoli E; Di Minno G
    Thromb Res; 2015 Dec; 136(6):1074-81. PubMed ID: 26508464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of anticoagulants: an overview of current developments.
    Greinacher A; Thiele T; Selleng K
    Thromb Haemost; 2015 May; 113(5):931-42. PubMed ID: 25832311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab.
    Hu TY; Vaidya VR; Asirvatham SJ
    Vasc Health Risk Manag; 2016; 12():35-44. PubMed ID: 26937198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies of neutralization of the direct oral anticoagulants effect: review of the literature.
    Jourdi G; Le Bonniec B; Gouin-Thibault I
    Ann Biol Clin (Paris); 2019 Feb; 77(1):67-78. PubMed ID: 30591426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When and How to Use Reversal Agents for Direct Oral Anticoagulants?
    Gómez-Outes A; Suárez-Gea ML; Lecumberri R
    Curr Cardiol Rep; 2023 May; 25(5):371-380. PubMed ID: 36976497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation and Management of Direct-Acting Anticoagulants for Emergency Procedures.
    Levy JH
    Am J Med; 2016 Nov; 129(11S):S47-S53. PubMed ID: 27569675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latest advances in the reversal strategies for direct oral anticoagulants.
    Escal J; Lanoiselée J; Poenou G; Zufferey P; Laporte S; Mismetti P; Delavenne X
    Fundam Clin Pharmacol; 2024 Aug; 38(4):674-684. PubMed ID: 38350629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding and antidotes in new oral anticoagulants.
    Majeed A; Schulman S
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):191-202. PubMed ID: 23953907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the development of specific antidotes for target-specific oral anticoagulants.
    Mo Y; Yam FK
    Pharmacotherapy; 2015 Feb; 35(2):198-207. PubMed ID: 25644580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Elective Surgery and Emergent Bleeding with Direct Oral Anticoagulants.
    Kaatz S; Mahan CE; Nakhle A; Gunasekaran K; Ali M; Lavender R; Paje DG
    Curr Cardiol Rep; 2017 Oct; 19(12):124. PubMed ID: 29064044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidotes for the direct oral anticoagulants: What news?
    Galliazzo S; Donadini MP; Ageno W
    Thromb Res; 2018 Apr; 164 Suppl 1():S119-S123. PubMed ID: 29703468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of antithrombotic agents.
    Bauer KA
    Am J Hematol; 2012 May; 87 Suppl 1():S119-26. PubMed ID: 22460529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.